Financial Synergies Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Financial Synergies Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15	Closed	-$659	–	90
2024 Q1	$659	Hold	15	–	–	﹤0.01%	441
2023 Q4	$421	Hold	15	–	–	﹤0.01%	387
2023 Q3	$690	Hold	15	–	–	﹤0.01%	421
2023 Q2	$863	Hold	15	–	–	﹤0.01%	393
2023 Q1	$563	Hold	15	–	–	﹤0.01%	407
2022 Q4	$421	Hold	15	–	–	﹤0.01%	387
2022 Q3	$422	Hold	15	–	–	﹤0.01%	375
2022 Q2	$522	Buy	+15	New	+$535	﹤0.01%	374

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Synergies Wealth Advisors's AMPH Position: Q2 2024 in Review

Financial Synergies Wealth Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 15 shares — an estimated $659 sold.

Financial Synergies Wealth Advisors first reported a position in AMPH in Q2 2022 and held it in 8 quarters. The position peaked at $863 in Q2 2023. 269 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

Financial Synergies Wealth Advisors reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Financial Synergies Wealth Advisors sold 15 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $659.
Financial Synergies Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 8 quarters.
Financial Synergies Wealth Advisors's Amphastar Pharmaceuticals position peaked at $863 in Q2 2023.
269 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Financial Synergies Wealth Advisors's 13F filing for Q2 2024, filed 23 Jul 2024.